Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Adenosine Therapeutics enters license agreement for adenosine receptor antagonists

June 15, 2000

Nerve growth factor related to increased irritant sensitivity in allergic rhinitis

June 15, 2000

PDE4-inhibitory respiratory therapeutics designed at Zambon

June 13, 2000

Phase II cumulative-dose trial of MSI-albuterol in adults successfully completed

June 13, 2000

New tryptase inhibitor effective against allergic airways inflammation in animal model

June 9, 2000

Good safety and evidence of persistent gene transfer obtained in phase I study of tgAAV-CF

June 8, 2000

Allegra now available to treat seasonal allergies and chronic hives in children

June 8, 2000

Discovery reports positive clinical results for SuperVent in cystic fibrosis

June 8, 2000

Ivax to develop treatment for cystic fibrosis with CBR

June 7, 2000

Worldwide approval sought for novel allergy and asthma therapy Xolair

June 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...